|Articles|November 9, 2008

aha day 1 images

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

aha day 1 images

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Sen. Roger Marshall's obstetrics practice sued more than 700 patients over unpaid bills

Bipartisan Senate bill would send $10 billion to primary care and rework how Medicare values physician work

10 ways AI is creeping into medical care

Hospital consolidation: Making primary care more integrated — and more expensive

Saving America's primary care system requires bold action now